VitaNova Life Sciences Corp Income Statement
VNOV|8 years of annual SEC 10-K data (FY2018-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
N/A
FY2025
Gross Profit
N/A
FY2025
Operating Income
N/A
FY2025
Net Income
N/A
FY2025
Revenue has grown at a 181.0% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Piotroski F-Score: 0/9 criteria passed
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | $2.7M | $570.7K | $38.0K | $120.0K | $0 | $0 | $0 |
| Cost of Revenue | - | $1.1M | $193.0K | $0 | - | - | - | $0 |
| Gross Profit | - | $1.6M | $377.7K | $38.0K | - | - | - | $0 |
| SG&A Expense | - | $158.1K | $86.8K | $62.2K | $133.4K | $52.1K | $72.3K | $71.8K |
| Operating Income | - | $1.2M | $205.6K | -$24.2K | -$13.4K | -$52.1K | -$72.3K | -$71.8K |
| Interest Expense | - | $4.5K | $0 | - | - | - | - | - |
| Income Tax | - | $353.6K | $64.9K | $0 | $0 | $0 | $0 | $0 |
| Net Income | - | $850.7K | $140.9K | -$24.2K | $139.7K | -$52.1K | -$72.3K | -$106.2K |
| EPS (Basic) | $0.01 | $0.00 | $0.02 | -$0.01 | - | - | - | - |
| EPS (Diluted) | $0.01 | $0.00 | $0.02 | -$0.01 | $0.00 | $0.00 | $0.00 | - |
| Shares Outstanding | 25.0M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 3.5M |
| Gross Margin | - | 59.2% | 66.2% | 100.0% | - | - | - | - |
| Operating Margin | - | 45.4% | 36.0% | -63.8% | -11.1% | - | - | - |
| Profit Margin | - | 32.0% | 24.7% | -63.8% | 116.4% | - | - | - |